Alvotech

Baliopharm AG is a biotechnology company based in Basel, Switzerland, with a subsidiary in Jülich, Germany. Founded in 2007, the company specializes in the development of innovative therapeutics aimed at treating immune-mediated inflammatory diseases and various forms of cancer. Its product portfolio includes treatments for autoimmune conditions such as rheumatoid arthritis, Crohn's disease, psoriasis, and multiple sclerosis. By focusing on these therapeutic areas, Baliopharm seeks to enhance treatment options available to healthcare providers, ultimately improving patient outcomes. As of April 2018, the company operates as a subsidiary of PROMETHERA Biosciences S.A./N.V.